A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients with Relapsed/Refractory Multiple Myeloma
Year: 2021
Type: conference-abstract
Source: Blood
Authors: Barry Paul, Michaela Liedtke, Jorge Monge, Maria Chaudhry, Robert M. Rifkin, Mitul D. Gandhi, Jack Khouri, Andrew Kin, Tibor Kovacsovics, Moshe Y. Levy, Ann Mohrbacher, William Schmidt, David S. Siegel, Rebecca W. Silbermann, Anna Louise Byrne, Tina Ncube, Michael Murphy, Lin Gu, Nishanthan Rajakumaraswamy, Mark Chao, Saad Z. Usmani
Institutions: Levine Cancer Institute, Stanford Cancer Institute, Stanford University, Weill Cornell Medicine, The Ohio State University, The US Oncology Network, Virginia Cancer Specialists, Cleveland Clinic, The Barbara Ann Karmanos Cancer Institute, Huntsman Cancer Institute, Baylor University Medical Center, University of Southern California, Hackensack University Medical Center, Oregon Health & Science University, Gilead Sciences (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3211813635